MYRIAD GENETICS INC (MYGN) Stock Analyst Ratings
NASDAQ:MYGN - Nasdaq - US62855J1043 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 69% to MYGN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.33. This target is 265.97% above the current price.
MYGN was analyzed by 23 analysts. The buy percentage consensus is at 69. So analysts seem to be have mildly positive about MYGN.
In the previous month the buy percentage consensus was at a similar level.
MYGN was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-21 | ScotiaBank | Downgrade | Sector Outperform -> Sector Perform |
| 2025-05-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-08 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-05-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-07 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-05-07 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-04-17 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-04-09 | Guggenheim | Downgrade | Buy -> Neutral |
| 2025-04-01 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-03-12 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2025-03-04 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-03-03 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-02-25 | UBS | Maintains | Neutral -> Neutral |
| 2025-02-25 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-02-12 | Craig-Hallum | Initiate | Buy |
| 2025-01-30 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-01-28 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-01-16 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2024-12-13 | B of A Securities | Maintains | Underperform -> Underperform |
| 2024-12-10 | UBS | Initiate | Neutral |
| 2024-12-09 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-11-18 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-11 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-09-19 | Morgan Stanley | Initiate | Equal-Weight |
| 2024-08-27 | Wells Fargo | Initiate | Overweight |
| 2024-08-13 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-08-13 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-08-07 | TD Cowen | Maintains | Hold -> Hold |
| 2024-08-07 | JP Morgan | Maintains | Underweight -> Underweight |
| 2024-06-27 | ScotiaBank | Initiate | Sector Outperform |